DROSHA and non-small cell lung carcinoma: Karube et al. found that Drosha and specifically Dicer expression levels were reduced in patients with non-small-cell-lung cancer (NSCLC) that correlated with poorly differentiated tumour status and shortened postoperative survival [61].